Ruotsalainen, J., Lopez‐Ramos, D., Rogava, M., Shridhar, N., Glodde, N., Gaffal, E., . . . Tüting, T. (2021). The myeloid cell type I IFN system promotes antitumor immunity over pro‐tumoral inflammation in cancer T‐cell therapy. Clin Transl Immunology.
Chicago Stili AlıntıRuotsalainen, Janne, Dorys Lopez‐Ramos, Meri Rogava, Naveen Shridhar, Nicole Glodde, Evelyn Gaffal, Michael Hölzel, Tobias Bald, ve Thomas Tüting. "The Myeloid Cell Type I IFN System Promotes Antitumor Immunity Over Pro‐tumoral Inflammation in Cancer T‐cell Therapy." Clin Transl Immunology 2021.
MLA AlıntıRuotsalainen, Janne, et al. "The Myeloid Cell Type I IFN System Promotes Antitumor Immunity Over Pro‐tumoral Inflammation in Cancer T‐cell Therapy." Clin Transl Immunology 2021.